Ideas4biologysp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-10-29
Share capital
5,000.00 PLN
Registered address
Poznań, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2021 – the filing deadline has passed.

  • 2021not filed
  • 202013/09/2021
  • 201914/10/2020
  • 201821/06/2019
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2020.

Results vs industry

Revenue
This companyUSD 53.91kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD -7.07kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 59.99kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 27.88kMedianUSD 133.19kAverageUSD 3.03m

Authorized Representatives

Paulina Grudzińska – President of the Management Board

Manner of representation

Each member of the management board is authorised to represent the company independently.

Ownership

OwnerSharesShare valueStake
Joanna Ciomborowska Basheerage 43
7$189.0914%
Izabela Alina Makałowskaage 63
9$243.1118%
Dariusz Stankiewiczage 47
26$702.3252%
Michał Szcześniakage 41
8$216.1016%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2015-04-17 to 2024-10-21.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

9 closed proceedings recorded in KRZ history.

Registration dateProceeding typeStatus
Aug 26, 2025
Discontinued enforcement proceedings
Closed
Aug 26, 2025
Discontinued enforcement proceedings
Closed
Aug 26, 2025
Discontinued enforcement proceedings
Closed
Aug 26, 2025
Discontinued enforcement proceedings
Closed
Aug 26, 2025
Discontinued enforcement proceedings
Closed

MSiG notices

Publication dateEvent
Jun 17, 2026Dissolution without liquidation opened
Mar 28, 2025Dissolution without liquidation opened

Public aid

9 public aid cases recorded, with a total value of $997,636.

PurposeGross amount
Aid for research and development projects: industrial research
$949.2K
Aid for research and development projects: experimental development
$38,439
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$189

European Funds

ProjectEU co-financing
Development of a high-throughput system enabling rapid assessment of the biological activity of compounds targeting the SARS-CoV-2 replication complex, identification of compounds with the highest therapeutic potential, and assessment of their cytotoxicity to human cells
$987.6K

Competitors

Name
GenxoneS.A.
Polbiotech Laboratoriumsp. z o.o.
Relvosp. z o.o.
Microblicsp. z o.o.
Xenstatssp. z o.o.
GenomtecS.A.
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.
Fungotechsp. z o.o.
Dystrogen TherapeuticsS.A.
MIMO BiotechP.S.A.

Change history

DateEvent
2024-11-21Address change
2024-02-13Address change
2021-05-28Address change
2020-12-29Address change
2017-06-28PKD change

FAQ

Last updated: 2026-04-09